NASDAQ : AIRS
$0.29 (6.97%)
| Source | Headline |
|---|---|
|
AIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI Solutions
HONG KONG & SEOUL, South Korea--(BUSINESS WIRE)--AIRS Medical (“the Company”), a global leader in AI solutions for medical imaging, today announced a strategic growth investment from TA Associates (“TA”), a leading global private equity firm. The investment will help fuel AIRS Medical's next phase of global expansion, advancement of its AI-powered radiology technology solutions and ongoing product innovation. Founded in 2018, AIRS Medical develops AI-native magnetic resonance imaging (“MRI”) ac. businesswire.com - 2026-06-16 10:00:00 |
|
Is Prisma AIRS Becoming Palo Alto Networks' Fastest Growth Engine?
Palo Alto Networks is seeing rapid adoption of Prisma AIRS, with customer growth and larger AI security deals boosting its revenue potential. zacks.com - 2026-06-10 11:10:48 |
|
AirSculpt Technologies Announces Participation in Upcoming Investor Conferences
MIAMI BEACH, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures, today announced that the Company will participate in upcoming investor conferences. globenewswire.com - 2026-05-27 16:05:00 |
|
AirSculpt Technologies Sees Sales Rebound, GLP-1 Tailwind for Body Contouring Growth
AirSculpt Technologies NASDAQ: AIRS executives said the body contouring company has returned to same-store sales growth after more than two years of declines, while outlining plans to expand services tied to GLP-1 weight-loss drug side effects and eventually resume clinic growth across the U.S. marketbeat.com - 2026-05-19 18:16:46 |
|
AirSculpt Technologies, Inc. (AIRS) Shareholder/Analyst Call Prepared Remarks Transcript
AirSculpt Technologies, Inc. (AIRS) Shareholder/Analyst Call Prepared Remarks Transcript seekingalpha.com - 2026-05-12 09:50:46 |
|
AirSculpt Technologies Q1 Earnings Call Highlights
AirSculpt Technologies NASDAQ: AIRS reported first-quarter fiscal 2026 results that management characterized as a “key turning point,” citing stabilized revenue, the first positive same-center sales result in more than two years, and continued debt reduction. Get AirSculpt Technologies alerts:Sign UpQ1 results: flat revenue, positive same-center sales, and margin expansion Chief Executive Officer Yogi Jashnani said the company “stabilized revenue year-over-year and delivered positive same-center sales for the first time in over two years,” while also expanding gross margin. marketbeat.com - 2026-05-08 16:07:26 |
|
AirSculpt Technologies, Inc. (AIRS) Q1 2026 Earnings Call Transcript
AirSculpt Technologies, Inc. (AIRS) Q1 2026 Earnings Call Transcript seekingalpha.com - 2026-05-08 14:21:15 |
|
AirSculpt Technologies Reports First Quarter Fiscal 2026 Results
MIAMI BEACH, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2026. globenewswire.com - 2026-05-08 06:30:00 |
|
AirSculpt Technologies Reports First Quarter Fiscal 2026 Results
MIAMI BEACH, Fla. , May 08, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ: AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2026. Yogi Jashnani, Chief Executive Officer, stated: "We had a solid start to the year delivering stabilization in revenue, positive same center sales, and a strengthened balance sheet in the first quarter. globenewswire.com - 2026-05-08 06:30:00 |
|
AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results
MIAMI BEACH, Fla., May 01, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report first quarter 2026 financial results before market open on Friday, May 8, 2026, to be followed by a conference call on the same day at 8:30 a.m. globenewswire.com - 2026-05-01 06:45:00 |